Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
about
Pituitary tumors. Current concepts in diagnosis and managementNeurology of the pituitary gland.Growth hormone and prostate cancer: guilty by association?Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.Growth hormone and tumour recurrenceSafety and efficacy of growth hormone replacement therapy in adults.Osteosarcoma and acromegaly: a case report and review of the literature.The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.Continuous versus intermittent subcutaneous infusion of octreotide in the treatment of acromegaly.Unanswered questions concerning the treatment of hyposomatotropism and hypogonadism in elderly men.The impact of octreotide in experimental proliferative vitreoretinopathy.Screening guidelines for colorectal cancer and polyps in patients with acromegaly.Colorectal neoplasia in acromegaly.Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.Lymphocyte subset pattern in acromegaly.Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.Adrenal morpho-functional alterations in patients with acromegaly.Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.Comparison of colonoscopy and fecal occult blood testing as a first-line screening of colonic lesions in patients with newly diagnosed acromegaly.Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study.
P2860
Q33608512-E839F5CD-8234-4C67-8CF7-6668DEA7CEF5Q33636102-A4324511-9E0B-452A-9DD0-7FA5C8C40CE0Q33708557-29952268-34CE-48C1-9F69-EAC5BD8C19C5Q33853206-9B28F8F8-30EC-4F8A-B7F3-AEDB72125995Q34445822-88CD6A40-96EC-44F8-95A7-75BF2C58A761Q35821424-D0A5F3FA-A3C8-47F3-8D59-FE4E60A867A6Q36299989-C32157A9-121C-42D6-9204-1BF0A9D62C71Q36720803-DF3852A4-73A2-4209-96E9-2DF72050D9D9Q38232848-756E3464-45B7-4BAF-B36C-495223940D4CQ40526147-D254D92A-314A-436B-BFF4-402D12932DE1Q40749572-A5D0D464-0A81-4E83-B094-1C39C3A07832Q41085758-D7B0CD61-FF7E-44BC-B891-90BF26BC09A8Q42079922-3DE784D9-0667-470E-9A33-C75675834BC7Q43087042-D762726E-1A19-4281-BC7A-7C9599FE5BB9Q43618401-728D79DA-7981-4174-AEB2-F117F9D40530Q43944314-F70A9FE5-0C46-4848-A201-54D6D17E112BQ43949709-1A8E6670-EF26-49D5-9210-6308F206D239Q46372452-4B3A6424-AADF-465C-BE43-DFC4A44BD78DQ50849700-441D5B8A-13A1-4F17-ABBD-3AC249E3BA6EQ51781235-542CA84C-53EC-4E94-966F-5D77BF446D2DQ53925916-6C1BD74E-6C8B-48D2-891C-E4BB2E19B139
P2860
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@en
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@nl
type
label
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@en
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@nl
prefLabel
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@en
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@nl
P356
P1476
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
@en
P2093
P304
P356
10.1210/JCEM-72-2-245
P407
P577
1991-02-01T00:00:00Z